Browse studies

Find your next paid study

27,370 recruiting studies available now

Optimizing Psychological Health and Preventing Clinical Problems: Testing the Effectiveness of an Evidence-Based Toolkit for Integrated Operational Support

Sub-clinical behavioral health services in the military are performed by BH technicians, who receive minimal training. Due to this, embedding more technicians …

Depression, AnxietyGriefLeadership+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

New York UniversityNCT06981598

Phase 2

Assessing Psyllium Given With Meals for Fructan Sensitivity in Children With Irritable Bowel Syndrome

The goal of this clinical trial is to learn if a fiber (psyllium) can change the way bacteria use fructans (a type of sugar) and whether psyllium can help decr…

Irritable Bowel Syndrome

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dr Bruno Chumpitazi, M.D.NCT06639984

Phase 1

A Phase 1 Adaptive Dose Escalation With Dose Expansion Study of Triapine in Combination With Temozolomide (TMZ) for Patients With Recurrent Glioblastoma

This phase I trial tests the safety, side effects, and best dose of triapine in combination with temozolomide in treating patients with glioblastoma that has c…

Recurrent Glioblastoma, IDH-WildtypeRecurrent WHO Grade 2 GliomaRecurrent WHO Grade 3 Glioma+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Northwestern UniversityNCT06410248

Observational

Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology

To develop novel optical imaging technologies for use as a non-destructive and minimally invasive tool for detection and diagnosis of various diseases that aff…

Gastrointestinal DiseaseGastrointestinal Dysfunction

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT04565704

Phase 1

A Phase 1/2 Open-label Multicenter Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of GTAEXS617 in Patients With Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of GTAEXS617 (REC-617) in participants w…

Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Observational

Individual Placement and Support (IPS) for Serious Mental Illness in Jalisco, Mexico

There is substantial data to suggest that the Individual Placement and Support (IPS) model, a the investigatorsll-known, evidence-based practice, can help peop…

Severe Mental Disorder

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Instituto Nacional de Psiquiatría Dr. Ramón de la FuenteNCT06019247

Phase 4

Corticosteroid for Diabetic Macular Edema (DME) Study

Our current goals include confirming inflammation mediators are biomarkers of DR and DME The Aim of this project is to measure aqueous PGE2 and inflammatory c…

Diabetic Macular Edema (DME)Diabetic Retinopathy

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07843849

Examining the Intervention Effectiveness of Hospital at Home for Improving Health Outcomes and Experiences for Patients, Clinicians, and Caregivers

The purpose of this study is to examine the implementation, intervention effectiveness, and dissemination of a digital acute care delivery model for improving …

ConditionsInfectionsHeart Failure+6 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

OSF Healthcare SystemNCT05952999

Phase 1

Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers

Healthcare workers and COVID-19 patients may experience psychological distress consequent to the pandemic, and are at particularly elevated risk for experienci…

Posttraumatic Stress Disorder

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Weill Medical College of Cornell UniversityNCT04887116

Phase 1

A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase Targeted Protein Degrader BGB-16673 in Patients With B-Cell Malignancies

Study consists of two main parts to explore tacabrutideg recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and mo…

B-cell MalignancyMarginal Zone LymphomaFollicular Lymphoma+7 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BeOne MedicinesNCT05006716

A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life

The purpose of this study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York Ci…

Cancer Patients

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT01742143

Phase 2

A Phase II Study of Daratumumab-Hyaluronidase for Chemotherapy-Relapsed/Refractory Minimal Residual Disease (MRD) in T Cell Acute Lymphoblastic Leukemia (T-ALL

In this study, the investigators are hypothesizing that daratumumab-hyaluronidase will effectively treat T-ALL in patients who have persistent or recurrent MRD…

T-cell Acute Lymphoblastic Leukemia

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Eastern Cooperative Oncology GroupNCT05289687